| Literature DB >> 27748343 |
Tian-Yi Liu1, Si-Yu Cai1, Xiao-Lu Nie2, Ya-Qi Lyu1, Xiao-Xia Peng3, Guo-Shuang Feng2.
Abstract
BACKGROUND: Robust statistical designing, sound statistical analysis, and standardized presentation are important to enhance the quality and transparency of biomedical research. This systematic review was conducted to summarize the statistical reporting requirements introduced by biomedical research journals with an impact factor of 10 or above so that researchers are able to give statistical issues' serious considerations not only at the stage of data analysis but also at the stage of methodological design.Entities:
Mesh:
Year: 2016 PMID: 27748343 PMCID: PMC5072263 DOI: 10.4103/0366-6999.191822
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
The statistical reporting guidelines and particular requirements for authors adopted by 23 press groups
| Press groups | ICMJE | NIHPG | SAMPL | CONSORT | STROBE | PRISMA | STARD | ARRIVE | Particular requirements | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oxford University Press | 9 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| American College Physicians | 8 | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| American Society Clinical Investigation | 8 | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| EMBO | 8 | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| JAMA | 8 | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| Science | 8 | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| BMJ | 7 | Yes | Yes | NA | Yes | Yes | Yes | Yes | NA | Yes |
| Chinese Medical Association | 7 | Yes | NA | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| Lancet | 7 | Yes | Yes | NA | Yes | Yes | Yes | Yes | NA | Yes |
| PLoS | 7 | NA | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes |
| Elsevier Inc. | 5 | Yes | Yes | NA | Yes | NA | NA | NA | Yes | Yes |
| American Thoracic Society | 4 | Yes | Yes | NA | Yes | NA | NA | NA | NA | Yes |
| American Society Clinical Oncology | 4 | Yes | Yes | NA | Yes | NA | NA | NA | NA | Yes |
| Massachusetts Medical Society-NEJM | 4 | Yes | Yes | NA | Yes | NA | NA | NA | NA | Yes |
| Wiley-Blackwell | 4 | Yes | Yes | NA | Yes | NA | NA | NA | NA | NA |
| Cell-press | 3 | NA | Yes | NA | NA | NA | NA | NA | Yrs | NA |
| Nature | 3 | NA | Yes | NA | Yes | NA | NA | NA | NA | Yes |
| Lippincott Williams and Wilkins | 2 | Yes | Yes | NA | NA | NA | NA | NA | NA | NA |
| American Association Cancer Research | 2 | Yes | Yes | NA | NA | NA | NA | NA | NA | NA |
| Landes Bioscience | 2 | Yes | Yes | NA | NA | NA | NA | NA | NA | NA |
| Cambridge University Press | 1 | NA | Yes | NA | NA | NA | NA | NA | NA | NA |
| Cold Spring Harbor Lab Press | 0 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Clockss | 0 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
NA: Not Available; ICMJE: The International Committee of Medical Journal Editors recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals; NIHPG: Principles and Guidelines for Reporting Preclinical Research addressed by The National Institutes of Health; SAMPL: Statistical Analyses and Methods in the Published Literature; CONSORT: Consolidated Standards of Reporting Trials; STROBE: Strengthening the Reporting of Observational Studies in Epidemiology; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-analyses; STARD: Standards for Reporting of Diagnostic Accuracy; ARRIVE: Animal Research: Reporting of In vivo Experiments.
Common items of statistical requirements issued by different reporting guidelines for biomedical research
| Common items | Total number | ICMJE | NIH | SAMPL | CONSORT | STROBE | PRISMA | STARD | ARRIVE |
|---|---|---|---|---|---|---|---|---|---|
| Outcomes and estimation (95% | 8 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Explanation of statistical methods | 7 | Yes | Yes | Yes | Yes | Yes | NA | Yes | Yes |
| Ancillary analyses methods (e.g., subgroup analysis) | 6 | Yes | NA | Yes | Yes | Yes | Yes | Yes | NA |
| Explanation of research design | 5 | Yes | NA | NA | Yes | Yes | NA | Yes | Yes |
| Inclusion and exclusion criteria of participants | 5 | NA | Yes | NA | Yes | Yes | Yes | Yes | NA |
| Estimation of sample size | 4 | NA | Yes | NA | Yes | Yes | NA | NA | Y |
| Definition of variables | 4 | NA | NA | Yes | Yes | Yes | Yes | NA | NA |
| Descriptive data (distribution, mean) | 4 | Yes | Yes | Yes | NA | Yes | NA | NA | NA |
| Participants recruitment | 3 | NA | NA | NA | Yes | NA | Yes | Yes | NA |
| Randomization methods | 3 | NA | Yes | NA | Yes | NA | NA | NA | Yes |
| Blinding methods | 3 | NA | Yes | NA | Yes | NA | NA | Yes | NA |
| Data sources and measurement | 3 | NA | NA | NA | NA | Yes | Yes | Yes | NA |
| Tables and figures | 3 | Yes | NA | Yes | NA | NA | NA | Yes | NA |
| Participant flow/numbers analyzed | 3 | NA | NA | NA | Yes | Y | NA | NA | Yes |
| Computer software | 3 | Yes | NA | Yes | NA | NA | Yes | NA | NA |
| Methods for test reproducibility | 2 | NA | Yes | NA | NA | NA | NA | Yes | NA |
| Baseline data | 2 | NA | NA | NA | Yes | NA | NA | NA | Yes |
| Demographic variables analysis | 2 | Yes | NA | Yes | NA | NA | NA | NA | NA |
| Terms and units standardization | 2 | Yes | NA | NA | NA | NA | NA | Yes | NA |
| Bias | 2 | NA | NA | NA | NA | Yes | Yes | NA | NA |
| Sampling | 2 | NA | NA | NA | NA | Yes | NA | Yes | NA |
| Alpha level setting | 1 | NA | NA | Yes | NA | NA | NA | NA | NA |
| Direction of hypothesis | 1 | NA | NA | Yes | NA | NA | NA | NA | NA |
| Adjustments for multiple comparisons | 1 | NA | NA | Yes | NA | NA | NA | NA | NA |
NA: Not available; ICMJE: The International Committee of Medical Journal Editors recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals; NIH: Principles and Guidelines for Reporting Preclinical Research addressed by The National Institutes of Health; SAMPL: Statistical Analyses and Methods in the Published Literature; CONSORT: Consolidated Standards of Reporting Trials; STROBE: Strengthening the Reporting of Observational Studies in Epidemiology; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-analyses; STARD: Standards for Reporting of Diagnostic Accuracy; ARRIVE: Animal Research: Reporting of In vivo Experiments; CI: Confidence interval.
Figure 1Improvements and supplements of statistical requirements addressed by different published guidelines.
Figure 2Frequency of particular statistical issues relevant to research design.
Figure 3Frequency of particular statistical issues relevant to method of analysis.
Figure 4Frequency of particular statistical issues relevant to presentation.